Rectify Pharma Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $96M

  • Investors
  • 7

Rectify Pharma General Information

Description

Developer of disease-modifying precision therapies designed to treat genetic diseases. The company develops positive functional modulators (PFMs) that are disease-modifying precision therapeutics to restore transporter function, enabling patients to recover from serious genetic diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 400 Technology Square
  • Second floor, Suite 201
  • Cambridge, MA 02139
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 400 Technology Square
  • Second floor, Suite 201
  • Cambridge, MA 02139
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rectify Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 14-Oct-2021 $96M Completed Pre-Clinical Trials
3. Seed Round Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view Rectify Pharma’s complete valuation and funding history, request access »

Rectify Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view Rectify Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Rectify Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of disease-modifying precision therapies designed to treat genetic diseases. The company develops positive fun
Drug Discovery
Cambridge, MA
17 As of 2026

Cambridge, MA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rectify Pharma Competitors (3)

One of Rectify Pharma’s 3 competitors is Casma Therapeutics, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Casma Therapeutics Venture Capital-Backed Cambridge, MA
Neuron23 Venture Capital-Backed South San Francisco, CA
Abeona Therapeutics Corporation Cleveland, OH
You’re viewing 3 of 3 competitors. Get the full list »

Rectify Pharma Patents

Rectify Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025151724-A1 Pyridinyloxypyridines as modulators of atp -binding cassette transporters and their use in treating medical conditions Inactive 12-Jan-2024
AU-2024400468-A1 Indole amide and related compounds and their use in treating medical conditions Pending 15-Dec-2023
EP-4824054-A1 Indole amide and related compounds and their use in treating medical conditions Pending 15-Dec-2023
WO-2025129023-A1 Indole amide and related compounds and their use in treating medical conditions Inactive 15-Dec-2023
WO-2024238871-A1 Aryl sulfonamide compounds and their use in treating medical conditions Inactive 18-May-2023 C07D471/04
To view Rectify Pharma’s complete patent history, request access »

Rectify Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rectify Pharma Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atlas Venture Venture Capital Minority
DC Investment Partners Venture Capital Minority
Forbion Venture Capital Minority
Longwood Fund Management Venture Capital Minority
Omega Funds Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Rectify Pharma FAQs

  • When was Rectify Pharma founded?

    Rectify Pharma was founded in 2020.

  • Where is Rectify Pharma headquartered?

    Rectify Pharma is headquartered in Cambridge, MA.

  • What is the size of Rectify Pharma?

    Rectify Pharma has 17 total employees.

  • What industry is Rectify Pharma in?

    Rectify Pharma’s primary industry is Drug Discovery.

  • Is Rectify Pharma a private or public company?

    Rectify Pharma is a Private company.

  • What is the current valuation of Rectify Pharma?

    The current valuation of Rectify Pharma is .

  • What is Rectify Pharma’s current revenue?

    The current revenue for Rectify Pharma is .

  • How much funding has Rectify Pharma raised over time?

    Rectify Pharma has raised $100M.

  • Who are Rectify Pharma’s investors?

    Atlas Venture, DC Investment Partners, Forbion, Longwood Fund Management, and Omega Funds are 5 of 7 investors who have invested in Rectify Pharma.

  • Who are Rectify Pharma’s competitors?

    Casma Therapeutics, Neuron23, and Abeona Therapeutics are competitors of Rectify Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process